Tingting Zhao1, Hong Liu1, Jibin Han2. 1. Department of Critical Care Medicine, The First Hospital of Shanxi Medical University, No. 85 Jiefangnan Road, Taiyuan, 030001, Shanxi, People's Republic of China. 2. Department of Critical Care Medicine, The First Hospital of Shanxi Medical University, No. 85 Jiefangnan Road, Taiyuan, 030001, Shanxi, People's Republic of China. hanjibin86@foxmail.com.
Abstract
PURPOSE: The purpose of this meta-analysis is to evaluate the effect of ethanol lock on the incidence of catheter-related bloodstream infection (CRBSI) in patients with central venous catheters. METHODS: RCTs comparing ethanol lock with another solution lock for prevention of CRBSI were obtained by searching databases of PubMed, Embase, Web of Science and Cochrane Central Register of clinical trials for eligible randomized controlled trials (inception to December 2017). Two researchers separately selected the RCTs and assessed their quality. Data on patient characteristics and ethanol protocols were collected. The primary outcome was the incidence of CRBSI, and the secondary outcomes were catheter colonization, exit infection and thrombosis. RESULTS: A total of 2575 patients with 3375 catheters from 7 eligible RCTs were included. Overall, ethanol lock significantly decreased the risk of CRBSI, with RR 0.54 (95% CI 0.38-0.78; I2 = 0%; p = 0.001); no obvious heterogeneity was observed in the fixed-effects model (I2 = 0%). Of note, subgroup analysis demonstrated that ethanol lock conferred significant benefit in studies with tunneled catheters (RR 0.46; 95% CI 0.30-0.72) but not in studies with untunneled catheters. Only two studies provided data regarding catheter colonization, and no significant difference was found (RR, 1.09; 95% CI, 0.87-1.38; I2 = 41%; p = 0.45). Moreover, pooled data did not show significant differences between ethanol and control groups with regard to the incidence of thrombosis (RR 1.05; 95% CI 0.91-1.22; I2 = 0%; p = 0.48). CONCLUSIONS: Our meta-analysis suggests that ethanol lock is effective on reducing the incidence of CRBSI in hemodialysis patients with tunneled central venous catheters.
PURPOSE: The purpose of this meta-analysis is to evaluate the effect of ethanol lock on the incidence of catheter-related bloodstream infection (CRBSI) in patients with central venous catheters. METHODS: RCTs comparing ethanol lock with another solution lock for prevention of CRBSI were obtained by searching databases of PubMed, Embase, Web of Science and Cochrane Central Register of clinical trials for eligible randomized controlled trials (inception to December 2017). Two researchers separately selected the RCTs and assessed their quality. Data on patient characteristics and ethanol protocols were collected. The primary outcome was the incidence of CRBSI, and the secondary outcomes were catheter colonization, exit infection and thrombosis. RESULTS: A total of 2575 patients with 3375 catheters from 7 eligible RCTs were included. Overall, ethanol lock significantly decreased the risk of CRBSI, with RR 0.54 (95% CI 0.38-0.78; I2 = 0%; p = 0.001); no obvious heterogeneity was observed in the fixed-effects model (I2 = 0%). Of note, subgroup analysis demonstrated that ethanol lock conferred significant benefit in studies with tunneled catheters (RR 0.46; 95% CI 0.30-0.72) but not in studies with untunneled catheters. Only two studies provided data regarding catheter colonization, and no significant difference was found (RR, 1.09; 95% CI, 0.87-1.38; I2 = 41%; p = 0.45). Moreover, pooled data did not show significant differences between ethanol and control groups with regard to the incidence of thrombosis (RR 1.05; 95% CI 0.91-1.22; I2 = 0%; p = 0.48). CONCLUSIONS: Our meta-analysis suggests that ethanol lock is effective on reducing the incidence of CRBSI in hemodialysis patients with tunneled central venous catheters.
Authors: Reineke A Schoot; C Heleen van Ommen; Theo Stijnen; Wim J E Tissing; Erna Michiels; Floor C H Abbink; Martine F Raphael; Hugo A Heij; Jan A Lieverst; Lodewijk Spanjaard; C Michel Zwaan; Huib N Caron; Marianne D van de Wetering Journal: Eur J Cancer Date: 2015-07-15 Impact factor: 9.162
Authors: Ioannis Chatzinikolaou; Kevin Finkel; Hend Hanna; Maha Boktour; John Foringer; Tam Ho; Issam Raad Journal: Am J Med Date: 2003-10-01 Impact factor: 4.965
Authors: Lennert Slobbe; Jeanette K Doorduijn; Pieternella J Lugtenburg; Abdelilah El Barzouhi; Eric Boersma; Willem B van Leeuwen; Bart J A Rijnders Journal: PLoS One Date: 2010-05-26 Impact factor: 3.240
Authors: Mário Cícero Falcão; Gabriela Ibrahim Martins de Castro; Juliana Valeria de Souza Framil; Juliana Zoboli Del Bigio; Ana Cristina Aoun Tannuri Journal: J Vasc Bras Date: 2022-07-06